The effect of lavender on the treatment of children with attention deficit hyperactivity disorder

The effect of lavender medicine as a supplementary drug in the treatment of children with attention deficit hyperactivity disorder

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017091612782N18

Enrollment

Registered

2017-10-15

Start date

2016-03-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder(ADHD). Disturbance of activity and attention

Interventions

Intervention 1: Intervention group: Patients under treatment with methylphenidate tablet and lavender. Intervention 2: Control group: Patients under treatment with methylphenidate tablet and placebo (

Treatment - Drugs

Intervention group: Patients under treatment with methylphenidate tablet and lavender

Control group: Patients under treatment with methylphenidate tablet and placebo (starch and lactose content)

Eligibility

Sex/Gender

All

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with attention deficit hyperactivity disorder (ADHD), age between 6 to 12 years. exclusion criteria: The patients with severe complications; People who do not have the consent to participate in the study; do not follow up.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Recovery rate. Timepoint: Before intervention and 8 weeks after intervention. Method of measurement: ADHD Rating Scale-IV.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshteh Shakibaei

Isfahan University of Medical Sciences

shakibaei@med.mui.ac.ir+98 31 3265 1574

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026